The Centers for Disease Control and Prevention’s Advisory Committee On Immunization Practices has released the 2020 recommended immunization schedule for adults.
The FDA has approved the first vaccine approved in the US for the prevention of dengue disease caused by all 4 serotypes of dengue virus in patients aged 9 through 16 years with laboratory-confirmed...
A new literature review aimed to update the information regarding the immunogenicity, duration of protection, effectiveness, and safety of rubella-containing vaccines.
To better understand completion rates of the recombinant zoster vaccine, researchers evaluated individuals who received the first dose and tracked who received the second dose, as well as the factors...
